Nicotine (transdermal): Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Aparna Vuppala (talk | contribs)
nocaptcha, Administrators
6,313 edits
No edit summary
WikiBot (talk | contribs)
Bots, Bureaucrats, bureaucrats, interwiki, nocaptcha, Administrators
57,550 edits
m Protected "Nicotine (transdermal)": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{DrugProjectFormSinglePage
{{DrugProjectFormSinglePage
|authorTag={{AV}}
|authorTag={{AV}}<!--Overview-->
 
 
<!--Overview-->
 
|genericName=Nicotine (transdermal)
|genericName=Nicotine (transdermal)
 
|aOrAn=a
 
|drugClass=[[depending agent]]
 
|indicationType=treatment
|aOrAn=
|indication=Reducing withdrawal symptoms, including nicotine craving, associated with quitting smoking
 
|adverseReactions=[[skin irritation]], [[nasal irritation]], nasal spray, oral irritation, [[dizziness]], [[headache]], [[insomnia]]
a
 
|drugClass=depending agent
 
 
 
|indication=
 
 
 
|hasBlackBoxWarning=
 
 
|adverseReactions=






<!--Black Box Warning-->
<!--Black Box Warning-->
 
|blackBoxWarningTitle=Title
|blackBoxWarningTitle=
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
Title
 
|blackBoxWarningBody=
<i><span style="color:#FF0000;">ConditionName: </span></i>


* Content
* Content
Line 41: Line 19:


<!--FDA-Labeled Indications and Dosage (Adult)-->
<!--FDA-Labeled Indications and Dosage (Adult)-->
 
|fdaLIADAdult=*Reduces [[withdrawal symptoms]], including nicotine craving, associated with quitting [[smoking]].
|fdaLIADAdult=
*Reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking.




Line 49: Line 25:


<!--Guideline-Supported Use (Adult)-->
<!--Guideline-Supported Use (Adult)-->
 
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
|offLabelAdultGuideSupport=
 
 
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


<!--Non–Guideline-Supported Use (Adult)-->
<!--Non–Guideline-Supported Use (Adult)-->
 
|offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
|offLabelAdultNoGuideSupport=
 
 
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


<!--Pediatric Indications and Dosage-->
<!--Pediatric Indications and Dosage-->


<!--FDA-Labeled Indications and Dosage (Pediatric)-->
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
 
|fdaLIADPed=There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
|fdaLIADPed=
 
 
 
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.


<!--Off-Label Use and Dosage (Pediatric)-->
<!--Off-Label Use and Dosage (Pediatric)-->


<!--Guideline-Supported Use (Pediatric)-->
<!--Guideline-Supported Use (Pediatric)-->
 
|offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
|offLabelPedGuideSupport=
 
 
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


<!--Non–Guideline-Supported Use (Pediatric)-->
<!--Non–Guideline-Supported Use (Pediatric)-->
 
|offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
|offLabelPedNoGuideSupport=
 
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


<!--Contraindications-->
<!--Contraindications-->
 
|contraindications=<!--Warnings-->
|contraindications=
|warnings=* If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider. [[Smoking]] can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.
 
* Condition1
 
<!--Warnings-->
 
|warnings=
 
* If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider. Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.


*Do Not Use
*Do Not Use


:*if you continue to smoke, chew tobacco, use snuff, use nicotine gum, or use another nicotine patch or other nicotine containing products
:*if you continue to [[smoke]], [[chew tobacco]], use snuff, use nicotine gum, or use another nicotine patch or other nicotine containing products


*Ask a doctor before use if you have
*Ask a doctor before use if you have


:*heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate.
:*Heart disease, recent heart attack, or irregular [[heartbeat]]. Nicotine can increase your [[heart rate.]]


:*high blood pressure not controlled with medication. Nicotine can increase your blood pressure.
:*high blood pressure not controlled with medication. Nicotine can increase your [[blood pressure]].


:*an allergy to adhesive tape or have skin problems, because you are more likely to get rashes
:*an allergy to adhesive tape or have skin problems, because you are more likely to get rashes
Line 129: Line 73:
:*skin redness caused by the patch does not go away after four days, or if your skin swells, or you get a rash
:*skin redness caused by the patch does not go away after four days, or if your skin swells, or you get a rash


:*irregular heartbeat or palpitations occur
:*irregular [[heartbeat]] or [[palpitations]] occur


:*you get symptoms of nicotine overdose, such as nausea, vomiting, dizziness, weakness and rapid heartbeat
:*you get symptoms of nicotine overdose, such as [[nausea]], [[vomiting]], [[dizziness]], [[weakness]] and rapid heartbeat


<!--Adverse Reactions-->
<!--Adverse Reactions-->


<!--Clinical Trials Experience-->
<!--Clinical Trials Experience-->
 
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
|clinicalTrials=
 
There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.




<!--Postmarketing Experience-->
<!--Postmarketing Experience-->
 
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
|postmarketing=
 
There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.




<!--Drug Interactions-->
<!--Drug Interactions-->
 
|drugInteractions=<!--Use in Specific Populations-->
|drugInteractions=
|FDAPregCat=D
 
|useInPregnancyAUS=There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
 
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
 
|useInNursing=There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
<!--Use in Specific Populations-->
|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
 
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
|useInPregnancyFDA=
|useInGender=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
 
|useInRace=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
 
|useInRenalImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with [[renal impairment]].
|useInPregnancyAUS=
|useInHepaticImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with [[hepatic impairment]].
 
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are [[immunocompromised]].
 
|useInLaborDelivery=
There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
 
|useInNursing=
There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
 
|useInPed=
There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
 
|useInGeri=
There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
 
|useInGender=
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
 
|useInRace=
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
 
|useInRenalImpair=
There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
 
|useInHepaticImpair=
There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
 
|useInReproPotential=
There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
 
|useInImmunocomp=
There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.


<!--Administration and Monitoring-->
<!--Administration and Monitoring-->
 
|administration=* Transdermal
|administration=
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
 
* Transdermal
|monitoring=
 
There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.






<!--IV Compatibility-->
<!--IV Compatibility-->
 
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
|IVCompat=
 
There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.


<!--Overdosage-->
<!--Overdosage-->
 
|overdose=There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
|overdose=
 
 
 
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.


<!--Pharmacology-->
<!--Pharmacology-->


<!--Drug box 2-->
<!--Drug box 2-->
 
|drugBox=<!--Mechanism of Action-->
|drugBox=
|mechAction=<!--Structure-->
 
|structure=<!--Pharmacodynamics-->
 
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
 
<!--Mechanism of Action-->
 
|mechAction=
 
 
 
<!--Structure-->
 
|structure=
 
 
 
<!--Pharmacodynamics-->
 
|PD=
 
There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.


<!--Pharmacokinetics-->
<!--Pharmacokinetics-->
 
|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
|PK=
 
There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.


<!--Nonclinical Toxicology-->
<!--Nonclinical Toxicology-->
 
|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
|nonClinToxic=
 
There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.


<!--Clinical Studies-->
<!--Clinical Studies-->
 
|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
|clinicalStudies=
 
There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.


<!--How Supplied-->
<!--How Supplied-->
 
|howSupplied=* store at 20-25°C (68-77°F)
|howSupplied=
 
* store at 20-25°C (68-77°F)


<!--Patient Counseling Information-->
<!--Patient Counseling Information-->
 
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
|fdaPatientInfo=
 
There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.


<!--Precautions with Alcohol-->
<!--Precautions with Alcohol-->
 
|alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
|alcohol=
 
* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.


<!--Brand Names-->
<!--Brand Names-->
 
|brandNames=<!--Look-Alike Drug Names-->
|brandNames=
|lookAlike=<!--Drug Shortage Status-->
 
* ®<ref>{{Cite web | title =  | url =  }}</ref>
 
<!--Look-Alike Drug Names-->
 
|lookAlike=
 
* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
 
<!--Drug Shortage Status-->
 
|drugShortage=
|drugShortage=
}}
}}
<!--Pill Image-->
<!--Pill Image-->


Latest revision as of 16:48, 20 August 2015

Nicotine (transdermal)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Nicotine (transdermal) is a depending agent that is FDA approved for the treatment of Reducing withdrawal symptoms, including nicotine craving, associated with quitting smoking. Common adverse reactions include skin irritation, nasal irritation, nasal spray, oral irritation, dizziness, headache, insomnia.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Nicotine (transdermal) in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Nicotine (transdermal) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Nicotine (transdermal) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Nicotine (transdermal) in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Nicotine (transdermal) in pediatric patients.

Contraindications

There is limited information regarding Nicotine (transdermal) Contraindications in the drug label.

Warnings

  • If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider. Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.
  • Do Not Use
  • if you continue to smoke, chew tobacco, use snuff, use nicotine gum, or use another nicotine patch or other nicotine containing products
  • Ask a doctor before use if you have
  • high blood pressure not controlled with medication. Nicotine can increase your blood pressure.
  • an allergy to adhesive tape or have skin problems, because you are more likely to get rashes
  • using a non-nicotine stop smoking drug
  • taking a prescription medicine for depression or asthma. Your prescription dose may need to be adjusted
  • When using this product
  • do not smoke even when not wearing the patch. The nicotine in your skin will still be entering your bloodstream for several hours after you take off the patch.
  • if you have vivid dreams or other sleep disturbances remove this patch at
  • Stop use and ask a doctor if
  • skin redness caused by the patch does not go away after four days, or if your skin swells, or you get a rash

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Nicotine (transdermal) in the drug label.

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Nicotine (transdermal) in the drug label.

Drug Interactions

There is limited information regarding Nicotine (transdermal) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): D There is no FDA guidance on usage of Nicotine (transdermal) in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Nicotine (transdermal) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Nicotine (transdermal) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Nicotine (transdermal) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Nicotine (transdermal) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Nicotine (transdermal) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Nicotine (transdermal) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Nicotine (transdermal) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Nicotine (transdermal) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Nicotine (transdermal) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Nicotine (transdermal) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Nicotine (transdermal) in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Transdermal

Monitoring

There is limited information regarding Monitoring of Nicotine (transdermal) in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Nicotine (transdermal) in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Nicotine (transdermal) in the drug label.

Pharmacology

There is limited information regarding Nicotine (transdermal) Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Nicotine (transdermal) Mechanism of Action in the drug label.

Structure

There is limited information regarding Nicotine (transdermal) Structure in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Nicotine (transdermal) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Nicotine (transdermal) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Nicotine (transdermal) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Nicotine (transdermal) in the drug label.

How Supplied

  • store at 20-25°C (68-77°F)

Storage

There is limited information regarding Nicotine (transdermal) Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Nicotine (transdermal) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Nicotine (transdermal) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Nicotine (transdermal) in the drug label.

Precautions with Alcohol

  • Alcohol-Nicotine (transdermal) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Nicotine (transdermal) Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Nicotine (transdermal) Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.



{{#subobject: 

 |Label Page=Nicotine (transdermal)
 |Label Name=Nicotine (transdermal)02.png

}}


{{#subobject: 

 |Label Page=Nicotine (transdermal)
 |Label Name=Nicotine (transdermal)03.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Nicotine_(transdermal)&oldid=1137127"